Australia, the healthiest nation: death, hospital and cost savings of the Preventative Health Taskforce target reductions for alcohol, 2007 to 2020 by Chikritzhs, Tanya et al.
 Australasian Medical Journal AMJ 2010, 3, 8, 499-503 
 
 











Please cite this paper as: Chikritzhs T, Whetton S, Daube 
M, Pascal R, Evans M. Australia, the healthiest nation: 
death, hospital and cost savings of the Preventative 
Health Taskforce target reductions for alcohol, 2007 to 

















The National Preventative Health Taskforce has set a 
30% target reduction in the proportion of risky and high-
risk drinkers by 2020. This study estimated the potential 
saving in deaths, hospitalisations and associated 
economic cost savings to premature mortality and 
health of achieving the target. 
 
Method   
Past national estimates of alcohol-attributable 
hospitalisations and deaths were used to forecast trends 
from 2007 to 2020. Estimated potential savings in 
deaths and hospitalisations were based on incremental 
decline in the prevalence of risky/high-risk drinking 
reaching a total of 30% by 2020 (about 2.3% per year). 
Associated economic costs of premature death were 
















(willingness to pay). Hospital costs were estimated 
from known trends in annual national costs for 
recent past years and taking inflation into account. 
 
Results 
A 30% reduction in risky/high-risk drinkers would 
avoid an estimated 7,200 deaths and some 94,000 
person-years-of-life lost due to premature death by 
2020. The estimated benefit to the health sector 
would include 330,000 fewer hospitalisations and 
1.5 million associated bed days. The net present 
value of these benefits is AUD 22.7 billion from 
deaths avoided and AUD 1.7 billion from fewer 
hospital separations totalling AUD 24.4 billion. 
 
Conclusion 
The potential savings in premature deaths, health 
and associated financial costs of a 30% reduction in 
risky and high-risk drinking by 2020 across the 
Australian population are considerable. 
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The National Preventative Health Taskforce 
(Taskforce) report, released in September 2009, sets 
out a National Preventative Health Strategy aimed at 
ensuring that Australia is “the healthiest nation” by 
2020. A starting point for the Strategy was to 
establish ambitious but achievable targets that 
respond to the need for “urgent, comprehensive and 
sustained action” (p. viii) in the three priority areas 
of obesity, tobacco and alcohol [1].  
 
We estimate the potential impact of the Taskforce’s 
30% target reduction in risky/high-risk drinkers 
(hereafter referred to as ‘Target’) on alcohol-
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attributable mortality (deaths, person-years-of-life lost) 
and morbidity (hospital separations, bed days). To 
achieve the 2020 Target, current prevalence (i.e. 2007) 
of risky/high-risk drinkers [2] would need to decline 
from 20.4% to 14.3% for short-term harm and from 





Population drinking prevalence estimates from the 2007 
National Drug Strategy Household Survey (NDSHS) 
served as the reference point for current alcohol 
consumption within Australia [3]. National estimates of 
alcohol-attributable mortality and morbidity were 
sourced from recent National Alcohol Indicators Project 
estimates [4].  
 
Population alcohol aetiologic fractions 
Estimates of alcohol-attributable mortality and 
morbidity were made by applying the population 
aetiologic fraction (PAF) method to unit records of 
deaths and hospitalisations. This method will be briefly 
summarised here as it has been described elsewhere in 
detail [5].  
 
For most chronic diseases, the PAF method combines 
knowledge of the strength of the causal association 
between alcohol and disease (i.e. relative risk [RR]), with 
estimates of drinking prevalence within the population. 
For injuries, RRs are less widely available and the PAF 
method typically relies on proportions of alcohol-
affected cases estimated from case-series studies. 
Alcohol-related conditions included the 41 conditions 
listed in Chikritzhs et al. [6] with the addition of type II 
diabetes, colorectal cancer and foetal alcohol syndrome 
with RRs sourced from the WHO [7] and Corrao et al. [8]. 
In keeping with current consensus [9] abstainers (self-
reported as having never consumed a full serve of 
alcohol) were used as the reference group. The formula 















i  = the exposure category (e.g. low risk, risky/high-
risk); 0 is the baseline category (non-exposed); 
AAFi  =  population alcohol aetiologic fraction for a 
particular category of exposure i; 
Pi   =  the estimated prevalence of the i
th category of 
exposure in the total population drawn from 
the 2007 NDSHS; 
RRi  =  the Relative Risk, for the i
th category of 
exposure relative to the reference category. 
 
Valuing alcohol-attributable mortality reductions 
Economic costs of premature death were estimated 
using the Value of a Statistical Life (VSL) method 
(willingness to pay). The VSL in Australia is estimated 
to be between 3 and 4 million AUD [10]. To estimate 
the dollar value accrued to avoided deaths, the mid-
point of this range was used (AUD 3.5 million), 
increasing annually in line with real per capita GDP 
(2% per annum calculated ‘peak-to-peak’ over the 
most recent economic cycle [11]).   
 
Benefits from averted mortality and morbidity were 
converted to present value terms using a real annual 
discount rate of 3% [12]. This is because the financial 
benefit is more valuable if realised today than in the 
future. The present value of benefits was also 
calculated using a 7% discount rate (the standard 
rate used in regulatory impact assessments [13]), to 
gauge sensitivity of the results. 
 
Estimating the effect of decreased risky/high-risk 
drinkers  
To estimate the impact of the Target, it was 
necessary to forecast annual alcohol-attributable 
mortality/morbidity from 2007 to 2020 using known 
mortality (1996-2006) and morbidity (1993/94-
2004/05) trends [4]. Allowing for population growth 
and changes in age distribution, the average annual 
change was 1.1% for deaths, 4.1% for 
hospitalisations and 2.8% for bed days. Linear 
forecasts to 2020 were based on the assumption 
that future mortality and morbidity trends would 
continue current trends. 
 
Estimates of person-years-of-life (PYL) were derived 
from 2006 mortality data using methods described 
in Ridolfo and Stevenson [14]. Forecasts to 2020 
were based on the assumption that PYL saved (e.g. 
from apparent cardio-protective effects of moderate 
drinking) and lost (e.g. injuries, cancers) would 
remain stable at about 6.6 and 15 respectively. It 
was conservatively assumed that no increase in life 
expectancy would occur during the forecast period. 
 
Forecast estimates of alcohol-related morbidity and 
mortality were subjected to two different drinking 
prevalence scenarios. Scenario (a) assumed that the 
prevalence of risky/high-risk drinkers remained 
constant at 2007 levels from 2007-2020. Scenario (b) 
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assumed that overall prevalence of risky/high-risk 
drinkers would decline incrementally by 2.3% per year, 
reaching 30% in 2020. The potential impact of the Target 
was measured as the difference between forecast 
estimates from scenarios (a) and (b). 
 
For scenario (b), it was also assumed that declines in 
risky/high-risk drinkers would: i) be equally distributed 
by age and sex; and ii) result from consumption 
reductions rather than total drinking cessation, moving 
risky/high-risk drinkers into the low-risk drinking group. 
That is, as the proportion of risky/high-risk drinkers 
declines, the proportion of low-risk drinkers increases at 
an equivalent magnitude, while the proportion of non-
drinkers remains unchanged.  
 
The potential impact of the 30% reduction in risky/high-
risk drinkers was measured as the difference between 
the morbidity and mortality estimates generated by 
scenarios a) and b). 
 
Hospital separation costs  
To estimate the potential economic impact of the Target 
on hospitalisations, separations avoided from 2007 to 
2020 were multiplied by forecast estimates of the 
average national cost per separation. From 2002/03 to 
2006/07 the average cost per separation nominally 
increased by 6% [15]. Conditions related to alcohol 
consumption have an average cost weight of 1.42, giving 
an average cost per alcohol-attributable separation of 
AUD 5,322. The average rate of inflation over this period 
was 3% [16], therefore, to forecast separation costs to 
2020 it was assumed that the cost per separation would 





Achieving a 30% reduction in risky/high-risk drinkers by 
2020 would increase the annual number of net lives 
saved from premature death attributable to alcohol (i.e. 
more deaths avoided), thereby accruing an additional 
7,286 lives saved by 2020 (see Figure 1). The PYL saved 
due to avoided deaths would sum to 94,421. The 
present value of the additional net lives saved by 2020 
would sum to AUD 22.69 billion (AUD 15.8 billion using a 
7% discount rate). 
 
Figure 1: Estimated annual net number1 of deaths 
avoided and person-years of life lost attributable to 
                                                 
1
 Estimates include mortality due to all alcohol consumption, i.e. low 
and risky/high-risk. 
 
alcohol consumption with regard to annual 


















































Deaths avoided: with annual reduction in risky/high risk drinking Deaths avoided: without change in risky/high risk drinking




Achieving the Target yields an estimated saving of 
327,998 separations and 1,448,649 bed days (see 
Figure 2) by 2020 with an estimated cost saving of 
approximately AUD 1.7 billion (AUD 1.2 billion using 
a 7% discount rate). 
 
Figure 2: Estimated annual net number2 of 
hospitalisations and bed days attributable to alcohol 
consumption with regard to annual reduction in 








































Hospt: with annual reduction in risky/high risk drinking Hospt: without change in risky/high risk drinking





Achieving a 30% reduction in risky/high-risk drinkers 
by 2020 would increase the proportion of low-risk 
drinkers. In Australia, the number of lives saved 
(mostly cardiovascular) from alcohol consumption 
typically exceeds lives lost, producing a net saving of 
lives. However, as the number of deaths due to 
heart disease has fallen, potential savings from 
                                                 
2
 Estimates include morbidity due to all alcohol consumption, 
i.e. low and risky/high-risk. 
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alcohol’s putative cardio-protective effects have also 
declined leading to a steady decline in the net number 
of lives saved over time [6]. If, however, a 30% reduction 
in risky/high-risk drinkers were to be achieved by 2020, 
thereby increasing the proportion of low-risk drinkers, 
declining annual numbers of net lives saved would be 
reversed, producing an estimated 7,286 additional lives 
saved. Unlike deaths per se, Australian PYL lost has 
always exceeded PYL saved [6] – mostly because PYL lost 
due to alcohol is particularly influenced by youthful 
injury deaths (e.g. road crashes) whereas potential lives 
saved from chronic disease largely occur among older 
age groups. Nevertheless, over time, the reduction in 
premature loss of life is substantial, accruing to over 
AUD 23 billion saved by 2020. 
 
Annual numbers of alcohol-attributable hospitalisations 
have increased steadily for over a decade [4, 6]. If left 
unchecked, this annual growth is likely to continue, 
contributing substantially to the burden on the health 
care sector. However, alcohol-attributable 
hospitalisations are potentially avoidable and a 30% 
reduction in risky/high-risk drinkers would save over 
330,000 hospitalisations and 1.5 million bed days by 
2020, saving over AUD 1.2 billion.  
 
Thus a total saving of some AUD 24.4 billion (AUD 17 
billion at the 7% discount rate) is achievable. This is 
based on the assumption that life expectancy will 
remain stable over time. If average life expectancy was 
to increase however, then PYL saved and associated 
financial savings would also increase. Policies which 
achieved the Target (e.g. volumetric tax, reduced trading 
hours, outlet density, restrictions on alcohol advertising 
and promotion through sport, labelling) would have a 
positive benefit cost ratio providing their annual cost 
was no more than AUD 1.6 billion (the annualised value 
of the benefits).  
 
These estimates include two major contributors to the 
economic burden of preventable alcohol-attributable 
disease and injury, but they do not provide a full 
account. An estimate of the total potential cost benefits 
would also require the inclusion of intangible costs of 
alcohol-attributable ill-health, and a range of other 
medical and non-medical costs (such as emergency 
department presentations, nursing homes, road traffic 
accidents, property damages, policing and courts). The 
types of costs included here, for instance, comprise only 
31 percent of the total social costs of alcohol misuse 
estimated for 2004/05 [17]. Future estimates might also 
include cost components associated with harm to others 
such as victims of violence, child neglect and passengers 
in road crashes.  
 
Conclusion 
Based on current understandings of the relationship 
between alcohol consumption, injury, disease and 
death a 30% reduction in risky/high-risk drinkers by 
2020 would potentially save Australia some AUD 
24.4 billion (AUD 17 billion at the 7% discount rate) 
in premature loss of life and hospitalisations.  
 
The Taskforce’s Target reflected a view that there is 
“increased community and political concern about 
the harmful consumption of alcohol…” (p. 238) and 
an increasingly solid base of evidence upon which 
policy decisions can be made [1]. Achieving the 
Target will not be easy, but will bring about 
substantial health and economic benefits. 
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